NEW YORK (GenomeWeb News) – Scientists at Brigham and Women's Hospital and Children's Hospital Boston will use a $4.2 million grant from the National Heart, Lung, and Blood Institute to identify genetic and epigenetic causes of congenital heart disease.

Funded through the NHLBI's Pediatric Cardiac Genomics Consortium, the researchers will relate genetic variants found in patients with congenital heart disease to clinical outcomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.